Bitome
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Bitome - overview
Established
2016
Location
Boston, MA, US
Primary Industry
Biotechnology
About
Based in Massachusetts, US, and founded in 2016, Bitome, Inc. operates as a biotechnology company that offers non-invasive life sciences tools for real-time volume status monitoring. The company was founded by its CEO, Herbert Ryan, Jens Höfflin, and Trevor Kemp. In June 2022, Ginkgo BioWorks, Inc.
acquired Bitome. The company offers a metabolomics (life chemistry)-based continuous monitoring platform for companies in the biotechnology sectors with fermentation and other biological manufacturing processes, which offers actionable insights, and tools to accelerate biological product development, as well as boost their bio-based products to market faster.
Current Investors
Illumina, Inc., Ginkgo BioWorks, Inc., Soaring Eagle Acquisition Corp.
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Analytics & Performance Software, Medical Software
Website
www.bitome.com
Verticals
Artificial Intelligence
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.